Skip to main content

Streamlining the Pathology Workflow Through Artificial Intelligence With Waqas Haque, MD, MPH, and Leif Honda of TriMetis

This second episode of Oncology Data Advisor's podcast series, Exploring Artificial Intelligence in Oncology, features Leif Honda, Chief Innovation Officer at TriMetis, a digital pathology company focused on improving patient outcomes by accelerating human tissue-based research, development, and testing. Dr. Waqas Haque, member of the Oncology Data Advisor Fellows Forum, speaks with Mr. Honda about the TriMetis Computer-Assisted Pathology (TCAP) AI platform, including how it was developed and trained, its capabilities for streamlining the pathology workflow, and the ongoing process of preparing it for clinical utility.  

Continue reading

HemePath Hub at CorePath: a Unique Learning Opportunity for Hematologic Cancers With Aamir Ehsan, MD, and Bridget Herschap, MD

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® sat down with Dr. Aamir Ehsan and Dr. Bridget Herschap from CorePath Laboratories. Dr. Ehsan and Dr. Herschap describe the HemePath Hub, a unique learning opportunity offered by CorePath in which pathologists, residents, and fellows can receive continuing educational training in the cutting-edge technology, business innovation, and specialized skills encompassing all aspects of pathology for hematologic cancers. 

Continue reading

Making Strides in Breast Cancer Treatment With Richard Zelkowitz, MD

Significant progress has been made in numerous facets of breast cancer care in recent years, including developments in treatment, imaging, pathology, radiation, and surgery. In this interview, Dr. Richard Zelkowitz, a Regional Medical Director of the Breast Program at Hartford HealthCare, highlights the advances that have been made and explains the importance of subspecialties in ensuring that patients with breast cancer receive the most individualized care possible.  

Continue reading

Revolutionizing Tissue-Based Research Through Pathology and Artificial Intelligence With Jon Wetzel and Leif Honda

At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Jon Wetzel, Chief Operating Officer (COO), and Leif Honda, Chief Innovation Officer (CIO) of TriMetis, a life sciences technology company, sat down with Oncology Data Advisor to talk about using artificial intelligence (AI) and computer-assisted pathology to revolutionize tissue-based research.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

Continue reading

Personalizing Cancer Diagnosis and Treatment Through Pathology: Aamir Ehsan, MD

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Aamir Ehsan, MD, Medical Director at CorePath Laboratories, spoke with Oncology Data Advisor to delve into the topic of personalized and precise diagnosis of cancer by pathology, a topic that he is passionate about other pathologists and oncologists understanding.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago, by Oncology Data Advisor and ConveyMed. 

Continue reading

Breast Cancer Pathology and Setting the Stage for Treatment: Lillie Shockney, RN, BS, MAS, HON-ONN-CG

·

In this new podcast, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and Medical Advisory Council member of the National Breast Cancer Foundation, discusses the pathology of breast cancer, prognostic factors for disease outcomes, and the crucial role of breast pathologists in setting the stage for diagnosis and treatment.

Continue reading

Breast Cancer Pathology and Setting the Stage for Treatment: Lillie Shockney, RN, BS, MAS, HON-ONN-CG

Lillie Shockney, RN, BS, MAS, HON-ONN-CG.

In this interview, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and Medical Advisory Council member of the National Breast Cancer Foundation, discusses the pathology of breast cancer, prognostic factors for disease outcomes, and the crucial role of breast pathologists in setting the stage for diagnosis and treatment. 

Continue reading